Stuka Paul 4/A
Research Summary
AI-generated summary
InspireMD (NSPR) Director Paul Stuka Buys 2,710 Shares
What Happened
Paul Stuka, a director of InspireMD, acquired 2,710 shares in an open-market purchase on December 9, 2025. The reported weighted average price was $1.81 per share, for a total cost of approximately $4,905. This was a purchase (transaction code P), which some investors view as a mildly bullish signal, though the dollar amount is modest.
Key Details
- Transaction date: December 9, 2025.
- Price: Weighted average $1.81 per share (footnote indicates trades ranged $1.80–$1.81; full breakdown available on request).
- Shares acquired: 2,710; total reported value: $4,905.
- Shares owned after transaction: Not disclosed in this amended filing.
- Filing: This is an amended Form 4 (filed Feb 23, 2026) that corrects the number of shares reported in Table I, Column 4; the original Form 4 was filed Dec 11, 2025 and no other changes were made (Exhibit 24.1: Power of Attorney included).
- Transaction code: P = Purchase.
Context
The purchase is small in dollar terms and is an open-market buy (not an option exercise, gift, or award). The amendment corrects a reporting detail rather than altering the nature of the trade. As always, insider purchases are factual signals of ownership change but do not by themselves explain motivation or predict future stock performance.